Clinical significance of the emergence of bacterial resistance in the hospital environment

被引:26
作者
Hosein, IK
Hill, DW
Jenkins, LE
Magee, JT
机构
[1] Cardiff Publ Hlth Lab, Dept Infect Prevent & Control, Cardiff, S Glam, Wales
[2] Cardiff & Vale NHS Trust, Cardiff, S Glam, Wales
关键词
D O I
10.1046/j.1365-2672.92.5s1.1.x
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Antibiotic resistance is an increasing threat in hospitals and both morbidity and mortality from infections are greater when caused by drug-resistant organisms. Whilst hospitals are universally blamed for this increase, there is an insufficient appreciation of external sources of resistance, such as when patients are admitted to hospitals from long-term care facilities in the community. The use of antibiotics in family practice and animal husbandry has also been linked to drug resistance being encountered in the hospital setting. Justifiable hospital antibiotic use, which can be life saving, may lead to 'collateral damage' with the emergence of resistance in non-target bacteria in the bowel, for example, with subsequent spread by cross-infection. At a management level, antibiotic resistance can have a significant impact on the ability of hospitals to maintain services since cohorting of patients and ward closures from outbreaks add to continuing bed shortages and waiting lists. Hospital laboratories must review their standard operating procedures since some resistance mechanisms may be missed by current methods of antibiotic susceptibility testing. With increasing public concern from press reports of 'multiresistant Staphylococcus aureus killer virus' and other drug-resistant organisms, there will inevitably be a push by national authorities for more surveillance data on antibiotic resistance; however, the cost-effectiveness of different surveillance strategies should be considered. Clinical governance and risk management are dominant themes in the National Health Service and hospital hygiene and antibiotic resistance are likely to feature prominently in audits related to these themes in the near future.
引用
收藏
页码:90S / 97S
页数:8
相关论文
共 57 条
[1]   Antibiotic resistance of Escherichia coli isolated from poultry workers, patients and chicken in the eastern province of Saudi Arabia [J].
Al-Ghamdi, MS ;
El-Morsy, F ;
Al-Mustafa, ZH ;
Al-Ramadhan, M ;
Hanif, M .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 1999, 4 (04) :278-283
[2]   Cost-effectiveness of pneumococcal vaccination of older people:: A study in 5 western European countries [J].
Ament, A ;
Baltussen, R ;
Duru, G ;
Rigaud-Bully, C ;
de Graeve, D ;
Örtqvist, Å ;
Jönsson, B ;
Verhaegen, J ;
Gaillat, J ;
Christie, P ;
Cifre, AS ;
Vivas, D ;
Loiseau, C ;
Fedson, DS .
CLINICAL INFECTIOUS DISEASES, 2000, 31 (02) :444-450
[3]   Antibiotic resistance in Spain: What can be done? [J].
Baquero, F ;
Baraibar, R ;
Campos, J ;
Dominguez, L ;
Garau, J ;
GarciaRodriguez, JA ;
Guerra, L ;
Palau, E ;
PerezGorricho, B ;
PerezTrallero, E ;
Prats, G ;
ReyDuran, R ;
Bremon, AR .
CLINICAL INFECTIOUS DISEASES, 1996, 23 (04) :819-823
[4]   The impact of antibiotic use on resistance development and persistence [J].
Barbosa, TM ;
Levy, SB .
DRUG RESISTANCE UPDATES, 2000, 3 (05) :303-311
[5]  
BRADLEY JS, 1991, PEDIATR INFECT DIS J, V10, P871
[6]   Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections [J].
Chien, JW ;
Kucia, ML ;
Salata, RA .
CLINICAL INFECTIOUS DISEASES, 2000, 30 (01) :146-151
[7]  
COHEN R, 1994, J CHEMOTHERAPY, V6, P17
[8]   A MAJOR OUTBREAK OF METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS CAUSED BY A NEW PHAGE-TYPE (EMRSA-16) [J].
COX, RA ;
CONQUEST, C ;
MALLAGHAN, C ;
MARPLES, RR .
JOURNAL OF HOSPITAL INFECTION, 1995, 29 (02) :87-106
[9]   Mopping up hospital infection [J].
Dancer, SJ .
JOURNAL OF HOSPITAL INFECTION, 1999, 43 (02) :85-100
[10]   PLASMIDS OF THE SAME INC GROUPS IN ENTEROBACTERIA BEFORE AND AFTER THE MEDICAL USE OF ANTIBIOTICS [J].
DATTA, N ;
HUGHES, VM .
NATURE, 1983, 306 (5943) :616-617